Results 21 to 30 of about 24,190 (185)

Restenosis following coronary angioplasty

Clinical Cardiology, 1991
AbstractRestenosis is the most important problem limiting the success of coronary angioplasty. Clinically, restenosis is seen in approximately one‐third of patients undergoing percutaneous transluminal coronary angioplasty. Several clinical and angiographic risk factors have been identified which may contribute to the development of restenosis ...
S P, Karas, E C, Santoian, M B, Gravanis
openaire   +2 more sources

Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.

PLoS ONE, 2013
BackgroundCoronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified.
Jeffrey J W Verschuren, Stella Trompet, M Lourdes Sampietro, Bastiaan T Heijmans, Werner Koch, Adnan Kastrati, Jeanine J Houwing-Duistermaat, P Eline Slagboom, Paul H A Quax, J Wouter Jukema   +9 more
doaj   +1 more source

Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement. [PDF]

PLoS ONE, 2010
Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of ...
Anne Braun, Lilibeth Dofiles, Serge Rousselle, Luis Guerrero, Jane Gunther, Ted Yednock, Alain Stricker-Krongrad, Elizabeth Messersmith   +7 more
doaj   +1 more source

Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study

Frontiers in Dental Medicine, 2021
Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue, Nidia C. Castro dos Santos, Nidia C. Castro dos Santos, Cassia F. Araujo, Flavio X. de Almeida, Magda Feres, Mauro P. Santamaria   +6 more
doaj   +1 more source

Prevention of Coronary Restenosis [PDF]

Circulation, 2000
Restenosis, the time-limited renarrowing of the lumen of a coronary artery, affects 20% to 40% of patients in the months after an initially successful intervention.1 2 As such, it represents the extreme form of the healing response that produces a normally distributed amount of late loss in lumen diameter at all interventional sites.3 To some extent ...
Richard E. Kuntz, Donald S. Baim
openaire   +1 more source

Results of Coronary Stenting for Restenosis

Journal of the American College of Cardiology, 1996
This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
COLOMBO, ANTONIO, FERRARO, MASSIMO, ITOH, AKIRA, MARTINI, GIOVANNI, BLENGINO, SIMONETTA, FINCI, LEO   +5 more
openaire   +2 more sources

Plasma levels of immunoinflammatory markers in De Novo coronary atherosclerosis and coronary restenosis postangioplasty

Arquivos Brasileiros de Cardiologia, 2001
OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis.
Alexandre Schaan de Quadros, Jorge Pinto Ribeiro, Waldomiro Carlos Manfroi, Cristiane Leitão, Karen Ordovás, Letícia Weiss, Nadine Clausell   +6 more
doaj   +1 more source

Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy

BMEMat, EarlyView.
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang, Jiawei Cui, Jin Wang, Manfred F. Maitz, Rifang Luo, Yunbing Wang   +5 more
wiley   +1 more source

Preclinical Serial Assessment of Virtual Physiology After Implantation of a Novel Endoluminal Resorbable Fibrillated Scaffold

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The resorbable fibrillated scaffold (RFS) is a novel electrospun, polylactide‐based endoluminal scaffold developed for peripheral arterial applications. Its porous microfibre architecture is intended to support host cell infiltration and vascular restoration.
Kotaro Miyashita, Lucas Hatzikostas, Emiliano Bianchini, Milosz Dziarmaga, Chun‐Ting Shih, Jouke Dijkstra, Eric K. W. Poon, Bart Sanders, Golo von Basum, Rick de Vries, Kim van Noort, Marc van Sambeek, Jos C. van den Berg, Albert Chinhenzva, Scot Garg, Yoshinobu Onuma, Patrick W. Serruys   +16 more
wiley   +1 more source

Pathogenetic mechanism of stented coronary arteries restenosis and the role of vasculoendothelial growth factor A [PDF]

Кардіохірургія та інтервенційна кардіологія, 2019
The contemporary issue of in-stent restenosis is reviewed in the article. The widespread use of interventional technologies for the treatment of acute and chronic forms of ischemic heart disease led to the appearance of the problem of coronary artery ...
M.P. Kopytsya, I.M. Kutya, I.R. Vyshnevska   +2 more
doaj   +1 more source